Research Collaboration

 
News Articles for Research Collaboration top ^
ClearOne's Spontania Media Collaboration Service Platform selected for its innovative features and ease of integration by Ideal TeleHealth, a telemedicine and remote wellness multi-solutions provider SALT LAKE CITY , Aug.
Sign-up for ClearOne Chosen By Ideal TeleHealth To Provide Video And Web Collaboration For Integration Into Its eHealth Services investment picks
2014/9/16
Company Leverages Connectivity, Community and Insights of Ariba® Network to Fuel More Agile, Intelligent and Collaborative Supply Chain WALLDORF, Germany , Sept.
Sign-up for SAP Ushers in New Era of Collaborative Supply Chain Management investment picks
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) and AbbVie Inc. (NYSE: ABBV) today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity’s oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.
Sign-up for Infinity and AbbVie Announce Global Strategic Collaboration to Develop and Commercialize Duvelisib (IPI-145) In Oncology investment picks
- Infinity to Receive $275 Million Upfront Payment and $530 Million in Potential Milestones - - Companies to Jointly Develop and Commercialize Duvelisib in U.S., with Equal Profit Share; Infinity to Receive Royalties on Sales Outside the U.S. - - Infinity to Host Conference Call Today at 8:30 A.M. ET/7:30 A.M. CT - CAMBRIDGE, Mass.
Sign-up for Infinity And AbbVie Announce Global Strategic Collaboration To Develop And Commercialize Duvelisib (IPI-145) In Oncology investment picks
2014/9/18
Video collaboration is quickly becoming one of the most effective means to communicate and collaborate in business today—and healthcare is no exception.
Sign-up for Polycom’s Top Six Ways Video Collaboration is Making a Positive Impact in Healthcare investment picks
2014/9/9
Optum Labs, the collaborative research and innovation center co-founded by Optum and Mayo Clinic, announced the addition of four new partners committed to improving the quality and value of patient care.
Sign-up for Four New Partner Organizations Join Optum Labs Research Collaborative investment picks
2014/7/24
SAN JOSE, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Today, Cisco unveiled new solutions that make it easier for customers to better support risk management and compliance for industrial control environments and connect experts for mission critical communications and collaboration.
Sign-up for Cisco Delivers Two New Industry Solutions to Protect Against Security Threats and Enhance Collaborative Decision Making investment picks
- New Research to Profile Whole Blood Samples of Patients Treated with a Biogen MS Therapy - - Regulus to Receive $2M Upfront with Potential Future Milestone Payments - LA JOLLA, Calif.
Sign-up for Regulus Enters Into New Collaboration Agreement with Biogen Idec to Identify microRNA Biomarkers in Multiple Sclerosis investment picks
BeyondBio™ Platform Enhances The Design and Engineering Process of Biological Solutions GERMANTOWN, Md.
Sign-up for Intrexon Enters into Technology Collaboration to Advance Animal Health Applications investment picks
Stratasys Ltd .
Sign-up for Stratasys to Acquire GrabCAD, a Leading 3D CAD Collaboration Platform investment picks
2014/9/24
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the establishment of a research collaboration with the University of Florida and the University of Pennsylvania to develop a gene therapy for the treatment of a rare genetic disease that causes childhood blindness.
Sign-up for Genzyme Collaborates on Gene Therapy for Rare Disease that Causes Childhood Blindness investment picks
NanoString Technologies, Inc.(NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has signed a multi-year, multi-investigator research collaboration with Harvard-affiliated Brigham and Women’s Hospital to accelerate the translation of genomic biomarker discoveries into clinical cancer diagnostics.
Sign-up for NanoString Collaborates with Brigham and Women’s Hospital in Boston to Accelerate Translation of Genomic Discoveries into Clinical Diagnostics in Oncology investment picks
- In Collaboration with Nexans, Victoria University, University of Cambridge - AUSTIN, Texas, Aug.
Sign-up for Collaboration and Evaluation Data of Superconductor Technologies Conductus Wire Presented at the Applied Superconductivity Conference investment picks
2014/9/23
Cigna (NYSE: CI) and ChoiceHealth doctors in Virginia are launching a collaborative care initiative to improve patient access to health care, enhance care coordination , and achieve the goal of improved health , affordability and patient experience .
Sign-up for ChoiceHealth and Cigna Start Collaborative Care Program to Improve Health and Lower Costs for Northern Virginia Customers investment picks
The Western Union Company (NYSE: WU), a leader in global payment services, today announced the launch of a new mobile money transfer service in the Ivory Coast in conjunction with the MTN Group (JSE: MTN). The new service, which builds upon the existing mobile money collaboration between the companies in Uganda, allows consumers in Ivory Coast who use MTN’s Mobile Money service to receive a Western Union ® money transfer transaction directly on their mobile phones.
Sign-up for Western Union Expands Collaboration with MTN Group; Launches Mobile Money Transfer Service in the Ivory Coast investment picks
5BARz International, Inc. (OTCQB:BARZ), ( www.5BARz.com ) ("5BARz" or “the Company") a technology leader in the cellular network extender industry, today announced that it has delivered its 5Barz dual band Network Extender to its previously announced collaboration partner, a major tier 1 carrier, for testing and qualification on its network.
Sign-up for 5BARz Announces Delivery of Its Dual Band Network Extender Devices to Collaboration Partner investment picks
Daiichi Sankyo and Charleston Laboratories will collaborate on development and commercialization; Charleston will supply all products and retain an option to co-promote in the United States TOKYO , PARSIPPANY, N.J. and JUPITER, Fla.
Sign-up for Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination Hydrocodone Products for Pain and Opioid-Induced Nausea and Vomiting (OINV) in the US investment picks
HILDEN , Germany and LONDON , July 28, 2014 /PRNewswire/ -- Collaboration aims to create and commercialize companion diagnostic using genomic data from plasma samples to guide the use of IRESSA for non-small cell lung cancer patients New blood test will build on QIAGEN's FDA-approved therascreen EGFR test and is planned to run on Rotor-Gene Q, member of the QIAsymphony family of automated instruments Project enabled by AstraZeneca master framework agreement adds to QIAGEN's growing portfolio of liquid biopsy solutions, which complement tissue-based testing solutions QIAGEN (NASDAQ: QGEN; Frankfurt , Prime Standard: QIA) today announced a collaboration agreement with AstraZeneca PLC (LSE, NYSE and OMX: AZN) for the co-development and commercialization of a liquid biopsy-based companion diagnostic to be paired with IRESSA, AstraZeneca's targeted therapy for
Sign-up for QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients investment picks
NEW YORK , July 24, 2014 /PRNewswire/ -- Lyfebulb, the International Pemphigus Pemphigoid Foundation (IPPF) and Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm : "IMNP."; "Immune" or "the Company"), announced a collaboration to increase awareness of unmet needs in treating bullous pemphigoid last night at an event attended by more than sixty patients, physicians, scientists and other interested parties.
Sign-up for Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Research Collaboration
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Research Clients  |  Next: Research Communities